How to make cardiology clinical trials more inclusive
There is urgency in developing strategies to foster representativeness and create a research enterprise that meets the needs of all people living with cardiovascular disease.
There is urgency in developing strategies to foster representativeness and create a research enterprise that meets the needs of all people living with cardiovascular disease.
Cardiology trials continue to under-represent certain population groups relative to disease distribution; this Perspective outlines strategies to foster representativeness and create a research enterprise that meets the needs of people living with cardiovascular disease.